EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 30-Apr-2025 09:08 ET (30-Apr-2025 13:08 GMT/UTC)

Abnormal prenatal blood test results could indicate hidden maternal cancers

NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development
Peer-Reviewed Publication

Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to screen for chromosomal disorders in the fetus. Cancers included colorectal, breast, lung and pancreatic cancers, as well as lymphoma, cholangiocarcinoma and renal carcinoma. The screening test analyzes placental DNA fragments circulating in the maternal bloodstream to identify an extra chromosome or to determine the baby’s sex. The study appears in the New England Journal of Medicine.

Journal: New England Journal of Medicine
Funder: NIH/National Institutes of Health

New research on chronic inflammation explores potential treatments for chronic diseases and cancer

Wayne State University - Office of the Vice President for Research
Peer-Reviewed Publication

A recently published study led by Wayne State University on a new approach to understanding chronic inflammation could lead to new advancements in the treatment of many debilitating medical conditions, including cancer.

Journal: Frontiers in Immunology

Genetic data from ‘biobanks’ may help improve prediction of effectiveness, side effects of common medications, study finds

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as the severity of any side effects.

Journal: Cell Genomics

How breast cancer cells survive in bone marrow after remission

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

A new study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

Journal: Journal of Clinical Investigation
Funder: NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute

MD Anderson Research Highlights: ASH 2024 Special Edition

University of Texas M. D. Anderson Cancer Center
Reports and Proceedings

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features upcoming oral presentations by MD Anderson researchers at the 66^th American Society of Hematology (ASH) Annual Meeting and Exposition, providing new insights and advances in hematological malignancies and diseases. All ASH content from MD Anderson can be found at MDAnderson.org/ASH.

Cancer risk declines in old age, new MSK research helps explain why

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.

Journal: Nature
Funder: NIH/National Cancer Institute, Mark Foundation For Cancer Research, GO2 for Lung Cancer

Research reveals how fructose in diet enhances tumor growth

Washington University in St. Louis
Peer-Reviewed Publication

Fructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn syrup as a sweetener in beverages and ultra-processed foods. New research from Washington University in St. Louis shows that dietary fructose promotes tumor growth in animal models of melanoma, breast cancer and cervical cancer. However, fructose does not directly fuel tumors, according to the study published Dec. 4 in the journal Nature. Instead, WashU scientists discovered that the liver converts fructose into usable nutrients for cancer cells, a compelling finding that could open up new avenues for care and treatment of many different types of cancer.

Journal: Nature
Funder: NIH/National Institutes of Health

NYU Abu Dhabi researchers develop a new material that removes a dangerous “forever chemical,” from drinking water

New York University
Peer-Reviewed Publication

Researchers at NYU Abu Dhabi (NYUAD) have developed an innovative cationic covalent organic framework (COF) that efficiently detects and removes perfluorooctanoic acid (PFOA), a harmful and persistent pollutant, from drinking water. This breakthrough addresses a global challenge of removing perfluorinated alkylated substances (PFAS), or “forever chemicals”, which raised environmental and health concerns due to their accumulation in water and links to severe health risks, including cancer and developmental issues.

Journal: Nature Communications

B7-H4 as a therapeutic target in adenoid cystic carcinoma

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – December 4, 2024 – A new editorial was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “B7-H4: A potential therapeutic target in adenoid cystic carcinoma.”

Journal: Oncotarget

New ASTRO survey finds that prior authorization delays lead to serious harm for people with cancer

American Society for Radiation Oncology
Reports and Proceedings

A new nationwide survey of 750+ radiation oncologists confirms that prior authorization harms people with cancer by causing treatment delays, abandoned treatments, hospitalizations and deaths. Findings also make clear that the problem of prior authorization is growing worse, with patients now experiencing longer radiation therapy treatment delays than during the height of the COVID-19 pandemic. Results of the survey, the latest in a series from the American Society for Radiation Oncology (ASTRO), reinforce the urgent need for Congress to pass prior authorization reform legislation and prevent further harm to people with cancer.